Salma K Jabbour

10PUBLICATIONS
123CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 22, 2026
Utilizing machine learning to identify multimodal signatures for patients who would benefit from the addition of tremelimumab to durvalumab and chemotherapy (TRIDENT).

|May 15, 2026
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.

|Jan 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.

Kristin A Higgins, Chen Hu, Helen J Ross

|Sep 26, 2025
Bridging the Gap: The Evolving Landscape of CNS Management in Small Cell Lung Cancer: Prophylactic Cranial Irradiation in the Modern Era.

Tafadzwa L Chaunzwa, Salma K Jabbour, Luke R G Pike

|Mar 06, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.

Lakshmi Rajdev, Gentry G King, Christopher H Lieu

|Dec 03, 2024
Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysis.

Ritesh Kumar, Chris L Hallemeier, Daniel T Chang

Pageof 2

Frequent Collaborators

2 joint publications

Erqi Liu Pollom

2 joint publications

Terence M Williams

2 joint publications

Matthew P Deek

1 joint publications

Shuai Zheng